Clinical Trial

Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America

Study acronym: NECTARINE
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational, retrospective study aims to understand the treatment patterns and outcomes of patients with pulmonary and extra-pulmonary neuroendocrine carcinomas (NEC) in Latin America (Brazil, Mexico, Argentina, and Peru). The research will collect data from medical records to analyze factors like patient demographics, diagnosis methods, tumor characteristics, treatment approaches, and disease progression. The study is non-interventional, meaning patient care will follow standard clinical practice, with data gathered via an electronic system.
Trial Details
NCT Number NCT07192991
Lead Sponsor Latin American Cooperative Oncology Group
Collaborators: Boehringer Ingelheim, Grupo Argentino de Investigación Clínica en Oncología, Grupo de Estudios Clínicos Oncológicos Peruano
Conditions Neuroendocrine Carcinomas, Lung Neuroendocrine Carcinoma
Enrollment 200 participants
Start Date 2025-11-03
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-25